Pages that link to "Q46417204"

The following pages link to A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601). (Q46417204):

Displaying 16 items.

• Neoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasis (Q26775081) (← links)
• Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study (Q33612711) (← links)
• Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck. (Q34623415) (← links)
• Refining docetaxel-containing therapy for gastric cancer (Q35445166) (← links)
• Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma (Q36403236) (← links)
• Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. (Q37644000) (← links)
• Recent advances in chemotherapy for advanced gastric cancer in Japan (Q37719335) (← links)
• A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. (Q38864811) (← links)
• Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor (Q45435712) (← links)
• DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer (Q48187540) (← links)
• Efficacy of pre‐operative chemotherapy with docetaxel, cisplatin, and S‐1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para‐aortic lymph nodes (Q50999929) (← links)
• RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer. (Q55551032) (← links)
• Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial (Q64108800) (← links)
• A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601) (Q84606457) (← links)
• Peripheral Blood Platelet-Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients (Q89939879) (← links)
• Conversion Surgery for Stage IV Gastric Cancer (Q91587408) (← links)